Evgen Pharma plc (LON:EVG) CEO Stephen Franklin caught up with DirectorsTalk to discuss the company’s maiden results, the two phase II trials and when we can expect them to report and news flow over the coming year.
Evgen Pharma plc (LON:EVG) CEO Stephen Franklin caught up with DirectorsTalk to discuss the company’s maiden results, the two phase II trials and when we can expect them to report and news flow over the coming year.
At a recent medical conference a colleague asked me what I thought of breast implants. The reason for her question it turned out is that she had breast cancer and is thinking about have breast reconstruction.
Breast cancer is a disease that overwhelmingly affects women, but men can get it too. Peter Bagnall is one of them. Peter, 56, who is from Birmingham, got in touch with BBC Radio 5 Live during
Drinking alcohol is a big part of celebrating the festive season for many people. But there’s a limit to how much we should be drinking on a weekly basis, no matter the time of year. It’s
Stephen Franklin, Chief Executive Officer of Evgen Pharma, said: “We were delighted with the positive breast cancer interim data showing good tolerability and efficacy in this very difficult to treat patient population and are hopeful that
There is perhaps nothing more divisive at Christmas lunch than Brussels sprouts. They are the Marmite of the vegetable world, you either love them or hate them. But increasingly, research suggests a taste for sprouts might
Cancer symptoms can vary depending on which part of the body is affected by a tumour. You could be at risk of a tumour if you have weight loss or unexplained pain. These are the most
Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, today announced that a trials-in-progress poster of the Company’s Phase II trial of SFX-01 in metastatic
Are you looking for a vegetable to spice up your diet in a healthy way? If yes, then broccoli, also called Brassica oleracea italica, is the vegetable you want. The dark green crucifer is not only
According to the Centres for Disease Control and Prevention (CDC), breast cancer is the most common cancer in women. In the US, one in eight women will develop breast cancer during her lifetime. Those statistics sound
A diagnosis of breast cancer can be terrifying. According to the CDC, Breast cancer is the most common cancer in American women of any race or ethnicity. Though the statistics might be scary, catching breast cancer
Evgen Pharma plc (LON: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that Steve Franklin, the Company’s CEO, will be presenting tomorrow evening at a ShareSoc Growth
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study* of more than 50,000 women published in Cancer. The study, which was
Barry Clare, Evgen’s Chairman, said: “I’m delighted to welcome Susan Clement-Davies to Evgen’s Board. Her extensive investment banking and life sciences experience will be of great value to the Company as we prepare for the commercialisation
Women who are early risers and function at their best in the morning are less likely to develop breast cancer, a study has claimed. Scientists who discovered the association also unearthed evidence of a causal link
Moses Musonga never thought men could get breast cancer until he was diagnosed with the disease in 2013. The 67-year-old Kenyan told the BBC that he was profoundly shock when doctors told him in 2013 that
Ken and Jane Gremling have shared everything since they got married in 1971, just three weeks after they started dating. But they never expected to receive identical breast cancer diagnoses within 6 months of each other.
Breast cancer is more commonly associated with women more than with men, affecting approximately one in eight women in their lifetimes. However, men can still be diagnosed with breast cancer, albeit in far rarer circumstances. While
Commenting on the Placing, Steve Franklin, CEO of Evgen Pharma, said: “We are very pleased to have raised these additional funds from new and existing shareholders. The funds provide Evgen with additional working capital for use